Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre
2014
Bacterial infections of free-living amoebae
2001
A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure
2001
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
2006 Standout
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
2004
Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems?
2005
Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU
2007
Molecular mechanisms of antibiotic resistance
2014 Standout
Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study
1996
Cystic fibrosis
2016 Standout
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Epidemiology of infection and current guidelines for infection prevention in cystic fibrosis patients
2015
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Viability ofPseudomonas aeruginosain cough aerosols generated by persons with cystic fibrosis
2014
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
2006
The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis
2003
Emerging Importance of Multidrug‐ResistantAcinetobacterSpecies andStenotrophomonas maltophiliaas Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)
2001
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
2002
In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus☆
2009 StandoutNobel
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Lung Infection in Patients With Cystic Fibrosis
2007
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
Multiple Antibiotic–Resistant Bacteria in Long‐Term‐Care Facilities: An Emerging Problem in the Practice of Infectious Diseases
2000
Drugs for bad bugs: confronting the challenges of antibacterial discovery
2006 Standout
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
2005
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
The Science of Antibiotic Discovery
2020 Standout
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 å resolution 1 1Edited by K. Nagai
1998
Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
2008
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
2006
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
2010
Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial
1995
Early antibiotic treatment forPseudomonas aeruginosaeradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols
2012
Antibiotic resistance in the environment
2021 Standout
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
2012
A Multifaceted Intervention to Reduce Pandrug‐ResistantAcinetobacter baumanniiColonization and Infection in 3 Intensive Care Units in a Thai Tertiary Care Center: A 3‐Year Study
2008
Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations
2013
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Tackling antibiotic resistance: the environmental framework
2015 Standout
Reducing implant-related infections: active release strategies
2006 Standout
Development of 18S rRNA-targeted Oligonucleotide Probes for Specific Detection of Hartmannella and Naegleria in Legionella – positive Environmental Samples
2001
Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001
2006
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Infections in Patients with Cystic Fibrosis
2014
Herpes Zoster
2013 Standout
Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia
2006
Antimicrobial resistance among gram-negative organisms in the intensive care unit
2003
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa
2007
Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning
2007
Severe viral respiratory infections in infants with cystic fibrosis
1998
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Detecting Stenotrophomonas maltophilia Does Not Reduce Survival of Patients with Cystic Fibrosis
2002
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Comparison of simplex algorithms
1985
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002
2005
Respiratory Syncytial Virus Prophylaxis in Special Populations: Is it Something Worth Considering in Cystic Fibrosis and Immunosuppression?
2011
Cross-biome metagenomic analyses of soil microbial communities and their functional attributes
2012 Standout
Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling
2003
Use of Random Amplified Polymorphic DNA PCR To Examine Epidemiology of Stenotrophomonas maltophilia and Achromobacter ( Alcaligenes ) xylosoxidans from Patients with Cystic Fibrosis
2001
An improved skmplex algorithm for dealing with boundary conditions
1986
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Inhibition of Lipid A Biosynthesis as the Primary Mechanism of CHIR-090 Antibiotic Activity in Escherichia coli
2007
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Optimization using the modified simplex method
1990
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Controlling Hospital-Acquired Infection: Focus on the Role of the Environment and New Technologies for Decontamination
2014
Global Comparison of the Membrane Subproteomes between a Multidrug-Resistant Acinetobacter baumannii Strain and a Reference Strain
2006
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
2003
Metallic Copper as an Antimicrobial Surface
2010 Standout
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
2005
Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii
2005
Burn Wound Infections
2006 Standout
Optimization by Direct Search: New Perspectives on Some Classical and Modern Methods
2003 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Multiple antibiotic resistance in Stenotrophomonas maltophilia
1997
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
Techniques and performance of the advanced regular simplex method
1991
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis
2010
PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
2011
Metagenomic Analysis of Apple Orchard Soil Reveals Antibiotic Resistance Genes Encoding Predicted Bifunctional Proteins
2010
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Acanthamoebaspp. as Agents of Disease in Humans
2003 Standout
Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC
2009 StandoutNobel
Design and evaluation of modified simplex methods
1982
Design and optimization of modified simplex methods
1985
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
A review of computational optimisation methods applied to sustainable building design
2013 Standout
Works of M. Denton being referenced
Role of anti-pseudomonal antibiotics in the emergence ofStenotrophomonas maltophilia in cystic fibrosis patients
1996
Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit
2004
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation
2013
Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients
2001
Survival and Growth of Burkholderia cepacia Within the Free-Living Amoeba Acanthamoeba polyphaga
2000
Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis
2003
Co-existent cross-infection with Streptococcus pneumoniae and group B streptococci on an adult oncology unit
1993
A five year outbreak of methicillin-susceptible Staphylococcus aureus phage type 53,85 in a regional neonatal unit
2000
Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis
2003
Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients
1997
Quality of prescribing of intravenous antibiotics in a district general hospital.
1991
An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis
2009
Transmission of colistin‐resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center
2002
Ten years of viral and non-bacterial serology in adults with cystic fibrosis
2007
A new selective differential medium for isolation ofStenotrophomonas maltophilia
1996
Correlation between genotype and -lactamases of clinical and environmental strains of Stenotrophomonas maltophilia
1999
Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium
2000
Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit
2005
Stenotrophomonas maltophilia
1997
A Review of Simplex Optimization in Analytical Chemistry
1978
Financial savings following the introduction of a cystic fibrosis electronic patient record system
2010